Consistent with the previous results, treatment with LDN-212320 upregulated the expression of EAAT2 in the motor cortex of YAPGFAP-CKO ALS mice, preventing neuronal loss and motor deficits (Figure 8). The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.